AI assistant
VITRAFY LIFE SCIENCES LIMITED — Report Publication Announcement 2025
Apr 27, 2025
66000_rns_2025-04-27_d45b8560-843f-4e7e-b4ba-389a80ae4608.pdf
Report Publication Announcement
Open in viewerOpens in your device viewer
==> picture [144 x 48] intentionally omitted <==
ASX ANNOUNCEMENT
28 April 2025
Vitrafy Q3 FY25 Investor Briefing
Vitrafy Life Sciences Limited (ASX: VFY), ( Vitrafy or Company ) will release its Quarterly Activities Report and Appendix 4C for the quarter ended 31 March 2025 on Tuesday, 29 April 2025.
Vitrafy will host an investor briefing at 9.00am (AEST) on Friday, 2 May 2025 to present the results.
The Company invites investors to join the briefing. To attend, please register via the following link: https://zoom.us/webinar/register/WN_ne0woJWrSwC89S75cgK_jg
After registering, you will receive a confirmation email containing information on how to join the briefing.
Investors are encouraged to submit any questions in advance to Vitrafy’s Investor Relations using the contact details below.
### ENDS ###
This announcement is authorised by the Company Secretary of Vitrafy Life Sciences Limited.
For further information contact:
Investor and Media Relations
Simon Martin Chief Financial Officer [email protected]
About Vitrafy
Vitrafy has developed a proprietary range of smart cryopreservation hardware and Lifechain™, a cloud-based software platform, to offer a complete cryopreservation solution. This integrated system ensures the preservation of biomaterial quality, empowering industries to retain the integrity of sensitive biological samples throughout the storage process. Vitrafy’s innovative approach combines cutting-edge technology and seamless software integration to optimise cryopreservation, ensuring reliability and efficiency in maintaining valuable biological assets. Vitrafy is headquartered in Melbourne, Australia, has an ISO13485 accredited Manufacturing Facility and Laboratory in Ballarat, Victoria and is listed on the Australian Securities Exchange (ASX: VFY).
For more information visit vitrafy.com.
Vitrafy Life Sciences Limited | Level 4, 96-100 Albert Road, South Melbourne VIC 3205 | ABN 48 622 720 254 T +61 3 4331 9974 | W www.vitrafy.com | E [email protected]